Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells
- PMID: 8316219
Enzymatic and pH modulation of mitomycin C-induced DNA damage in mitomycin C-resistant HCT 116 human colon cancer cells
Abstract
The effect of pH and oxygen on DNA alkylation by mitomycin C (MMC) was studied with cell fractions and intact cells. The cell lines used were the HCT 116 human colon cancer cell line and a MMC-resistant subline (HCT 116-R30A) that has 5% of the quinone reductase activity present in the parent cell line. Microsomal fractions of the two cell lines catalyzed MMC-DNA adduct formation only under anaerobic conditions with equal efficiency. However, the pH of the reaction controlled the production of four identified and two unidentified adducts. Soluble fractions from each cell source catalyzed MMC-DNA adduct formation under aerobic and anaerobic conditions similarly. At higher pH, limited DNA adducts were produced by MMC activated by soluble fractions from either cell source. At lower pH, more DNA adducts were obtained with MMC activated by the soluble fraction of HCT 116 cells than with that activated by the soluble fraction of HCT 116-R30A cells. Four of these adducts were identified as N2-(2" beta,7"-diaminomitosene-1" alpha-yl)-2'-deoxyguanylic acid, N2-(2" beta,7"-diaminomitosen-1" beta-yl)-2'-deoxyguanylic acid, N2-(10"-decarbamoyl-2",7"-diaminomitosen-1" alpha-yl)-2'-deoxyguanylic acid, and N2-(2" beta,7"-diamino-10"-deoxyguanyl-N2-yl-mitosen-1" alpha-yl)-2'- deoxyguanylic acid. Acidic intracellular pH enhanced the cytotoxicity of MMC for HCT 116 cells, decreasing the IC50 from 0.3 +/- 0.04 microM to 0.1 +/- 0.03 microM, but pH had limited effect on the cytotoxicity of MMC for HCT 116-R30A cells. When intracellular pH was decreased, interstrand DNA cross-linking by MMC increased to a greater extent in HCT 116 cells than in HCT 116-R30A cells. Only two DNA adducts, each at low intensity, were detected in HCT 116-R30A cells treated at pH 6.0 and 7.6 and in HCT 116 cells treated at pH 7.6. However, six radioactive spots were detected in HCT 116 cells treated at pH 6.0. Three of these adducts were identified. This is the first direct evidence that acidic intracellular pH enhances MMC-DNA adduct formation in tumor cells containing high quinone reductase activity. Results from this study further confirm that pH and not enzyme is the determining factor in the distribution of types of MMC-DNA adducts. This study also indicates that low intracellular pH enhances the activity of quinone reductase in reducing MMC, which is important for aerobic cytotoxicity of MMC against tumor cells with high concentration of quinone reductase.
Similar articles
-
Effect of pH on DNA alkylation by enzyme-activated mitomycin C and porfiromycin.Mol Pharmacol. 1993 Jun;43(6):863-9. Mol Pharmacol. 1993. PMID: 8391116
-
NAD(P)H:quinone oxidoreductase expression and mitomycin C resistance developed by human colon cancer HCT 116 cells.Cancer Res. 1995 Jan 15;55(2):330-5. Cancer Res. 1995. PMID: 7812966
-
The role of NAD(P)H:quinone oxidoreductase in mitomycin C- and porfiromycin-resistant HCT 116 human colon-cancer cells.Cancer Chemother Pharmacol. 1992;31(1):23-31. doi: 10.1007/BF00695990. Cancer Chemother Pharmacol. 1992. PMID: 1458556
-
[DT-diaphorase].Gan To Kagaku Ryoho. 1997 Sep;24(11):1606-10. Gan To Kagaku Ryoho. 1997. PMID: 9309161 Review. Japanese.
-
[Recent advanced studies on mitomycins, antitumor activity and mode of action].Gan To Kagaku Ryoho. 1987 Jul;14(7):2396-409. Gan To Kagaku Ryoho. 1987. PMID: 3111386 Review. Japanese.
Cited by
-
Cytotoxic mechanisms of anti-tumour quinones in parental and resistant lymphoblasts.Br J Cancer Suppl. 1996 Jul;27:S23-7. Br J Cancer Suppl. 1996. PMID: 8763840 Free PMC article.
-
Mapping DNA adducts of mitomycin C and decarbamoyl mitomycin C in cell lines using liquid chromatography/ electrospray tandem mass spectrometry.Chem Res Toxicol. 2008 Dec;21(12):2370-8. doi: 10.1021/tx8002615. Chem Res Toxicol. 2008. PMID: 19053323 Free PMC article.
-
Dorzolamide synergizes the antitumor activity of mitomycin C against Ehrlich's carcinoma grown in mice: role of thioredoxin-interacting protein.Naunyn Schmiedebergs Arch Pharmacol. 2015 Dec;388(12):1271-82. doi: 10.1007/s00210-015-1163-9. Epub 2015 Aug 12. Naunyn Schmiedebergs Arch Pharmacol. 2015. PMID: 26264806
-
Enzymology of bioreductive drug activation.Br J Cancer Suppl. 1996 Jul;27:S1-8. Br J Cancer Suppl. 1996. PMID: 8763836 Free PMC article. Review. No abstract available.
-
NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones.Biochem Pharmacol. 2012 Apr 15;83(8):1033-40. doi: 10.1016/j.bcp.2011.12.017. Epub 2011 Dec 24. Biochem Pharmacol. 2012. PMID: 22209713 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources